Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al
For tirzepatide, with a similar half-life, the same guidance applies
Our approach involves a personalized plan that combines GLP-1 receptor agonists with lifestyle modifications, including dietary adjustments and exercise
Once they do find a legal, licensed compounding facility, there are still unresolved questions about where compounders are sourcing their active ingredients, whether anyone is safety-testing those products, and whether they are manufacturing them in a sterile environment
the dosing sections above separate weight-loss, cardiovascular, kidney, blood-sugar, and maintenance goals before a target dose is chosen